Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.63% vs -12.08% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 34.62% vs -19.84% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 7.54% vs -16.84% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 15.78% vs -13.79% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Pharmaron Beijing Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.63% vs -12.08% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.80% vs -2.75% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 34.62% vs -19.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -56.99% vs 93.17% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 7.54% vs -16.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 112.44% vs -50.06% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 15.78% vs -13.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -25.72% vs 55.20% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






